Abstract: Abstract: In recent years, the incidence of prostate cancer in China has increased significantly. At thesame time,compared with developed countries, the mortality rate of prostate cancer in China is higher. In the past decade, the relevant research on biomarkers for the diagnosis of prostate cancer has made great progress, and the evidence base for the detection of these markers is also rapidly developing. We reviewed a large number of literatures and reviewed the latest developments in the field of prostate cancerbiomarker testing in order to provide a reference for clinical medical staff to make better decisions.

Key words: prostatic neoplasms, prostate-specific antigen, biomarkers, tumor, exosomes, prostate cancer antigen 3, prostate health index